The Ordinary Retinol 0.2% in Squalane Serum (30mL)
৳ 1800 Original price was: ৳ 1800.৳ 1500Current price is: ৳ 1500.
A water-free solution with 0.2% pure Retinol to help reduce the appearance of fine lines and general skin aging. Formulated in Squalane for improved surface hydration.
Add ৳ 6200 to cart and get free shipping!
Introduce The Ordinary Retinol 0.2% in Squalane, a water-free solution designed to support the appearance of healthier-looking skin. This treatment combines a low concentration of Retinol, a well-researched ingredient known for its topical benefits, with Squalane, a non-comedogenic emollient.
Retinol helps address common skin texture concerns, working over time to visibly smooth the surface of the skin. The addition of Squalane aids in protecting against the moisture loss that can sometimes be associated with retinol use, ensuring the formula is comfortable and hydrating. This lightweight, oil-based serum is an excellent choice for those introducing their skin to retinoids or for individuals seeking a gentle, foundational retinol product as part of their evening routine. Apply a small amount in the evening after water-based serums but before heavier creams.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Toner/Toner Pad
Reviews
There are no reviews yet.